21.2 percent of U.S. adults had diagnosed arthritis from 2019 to 2021
Oct 12, 2023
Age-standardized prevalence rates were higher among women than men, veterans than nonveterans and non-Hispanic whites.
Discordance seen in self-reported, actual comorbidities in Native American adults
Jul 18, 2023
One-third reported having no comorbidities despite cardiometabolic markers classifying half to 80%.
BP genetic risk score linked to risk for CV events in type 2 diabetes
Apr 04, 2022
Each standard deviation increase in BP polygenic risk score was linked to a 12% increased hazard of adverse cardiovascular events.
Prior statin use linked to reduced risk for death in COVID-19
Jul 21, 2021
The risk for death was significantly reduced with prior statin and/or antihypertensive use among those with a history of cardiovascular and/or hypertension.
Replacing sitting for a few minutes of activity each day shows health benefits
Dec 13, 2023
30 extra minutes of moderate-to-vigorous physical activity was tied to drops in body mass index.
Preexisting type 2 diabetes tied to later stage of cancer diagnosis
Dec 02, 2022
An increased risk was seen for nonscreenable cancers.
Strength of risk factors for stroke vary by age
Jan 20, 2023
The association of hypertension, heart disease and diabetes with stroke appears to be substantially reduced at older ages.
US surgeon general announces national plan to fight ‘loneliness epidemic’
May 02, 2023
Loneliness can lead to pain, depression and shorter life spans in older adults and can impact sleep, inflammation and the immune system in younger adults.
Team care with clinical decision support system beneficial for type 2 diabetes patients
Dec 06, 2022
Significantly greater decreases were seen in HbA1c levels, LDL-C levels and systolic blood pressure for team-based care with versus without a clinical decision support system.
Monoclonal antibody therapy may cut COVID-19 hospitalizations
Aug 31, 2021
Lower hospitalization rates were seen at 14, 21 and 28 days for high-risk patients with mild-to-moderate COVID-19 who received casirivimab-imdevimab.